IDEXX Laboratories, Inc. (IDXX) experienced an 11.55% surge in its stock price during Friday morning trading, fueled by its better-than-expected fourth-quarter 2024 financial results.
Currently trading at $470.78 on the Nasdaq, IDEXX's stock has risen by $48.73. The trading session has seen significant activity with the stock reaching a high of $474.51 and a low of $473.46, with a total volume of 10,599 shares. The stock had previously closed at $422.05.
For the entirety of 2024, IDEXX reported a total revenue of $3.898 billion, marking a 6% increase. The earnings per share for the fourth quarter stood at $2.62, representing a 13% increase from the same period last year, indicating an expansion in operating margins.
The company posted revenues of $954 million, also showing a 6% rise compared to the previous year, largely due to robust growth in the Companion Animal Group, evidenced by a 6% increase in recurring revenue from diagnostics.
This strong performance has bolstered investor confidence, leading to an upward movement in the company's stock price.
